Key result
Low-dose oral vitamin K linked to an absolute ~25% increase in target-range INRs.
Why the study?
The effect of daily low-dose oral vitamin K supplementation on reducing variations in INRs in patients taking warfarin with unexplained INR fluctuations needed to be determined.
Does daily low-dose oral vitamin K supplementation reduce variations in the international normalized ratios (INRs) in patients taking warfarin with unexplained fluctuations?
Observational (n=8)
No
Does daily low-dose oral vitamin K supplementation reduce variations in the international normalized ratios (INRs) in patients taking warfarin with unexplained fluctuations?
Daily low-dose oral vitamin K supplementation may improve INR stability and time in therapeutic range in warfarin-treated patients with unexplained INR fluctuations.
Answers are grounded in this paper and cite their sources.
May support low-dose vitamin K for INR stability in select warfarin patients; hypothesis-generating and requires randomized confirmation before practice change.
Study Objective. To determine the effect of daily low‐dose oral vitamin K supplementation on reducing variations in the international normalized ratios (INRs) in patients taking warfarin. Design. Retrospective analysis. Setting. Anticoagulation clinic in a large, private‐practice hematology group. Patients. Eight motivated patients (three men, five women), aged 45–79 years, receiving anticoagulant therapy with warfarin, whose INRs had been fluctuating for reasons not associated with identifiable changes in diet, warfarin dosage, activity level, illness, or changes in drug therapy. Intervention. Daily supplementation with oral vitamin K, starting with 100 μg/day. Measurements and Main Results. Anticoagulation providers monitored INR responses; all documented INR values were included in the analysis, even those intentionally allowed outside the therapeutic range when dosages were adjusted for procedures. After dietary vitamin K supplementation, INR fluctuations diminished in nearly all patients. Overall, a significant decrease was noted in the INR standard deviation (p<0.05), and more INRs were in the therapeutic range after the start of supplementation. Allowing for small fluctuations on either side of the target range, the number of INRs within 0.2 units of the target range increased from 32% to 57% (relative increase 76%). Time in range also increased by a similar degree. Conclusion. Supplementation with daily low‐dose oral vitamin K significantly increased the number of INRs in range as well as the time in range, and decreased INR fluctuation in this small series of selected patients.
No takes yet. Share an insight, caveat, or question.
Reese et al. (2005) conducted an observational in Unstable anticoagulation control on warfarin (n=8). Daily oral vitamin K supplementation vs. Pre-supplementation baseline was evaluated on INR standard deviation and percentage of INRs within 0.2 units of the target range (p=<0.05). Daily low-dose oral vitamin K supplementation decreased INR standard deviation and increased INRs within 0.2 units of target range from 32% to 57%.
Synapse has enriched 10 related papers. Consider them for comparative context: